The overarching goal of this trial is to develop mechanisms to improve cardiovascular care among such prostate cancer patients receiving ADT by increasing patient awareness of individualized cardiovascular risk estimates and mitigation opportunities. Patients will be given access to a web-based quality improvement tool to educate patients of cardiovascular risks in prostate cancer and to inform them of their individualized, estimated cardiovascular risk and guideline-based risk mitigation recommendations. The study will assess the feasibility of this web-based application as a cardiovascular education tool for patients with prostate cancer. The study will also evaluate if completion of the web-based tool improves cardiovascular care access and risk mitigation for patients with prostate cancer.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
100
The CARE-PC app is a pragmatic, patient-oriented, web-based application that enables the education of patients regarding cardiovascular (CV) risks and collects CV and prostate cancer-related risk variables and CV care access data from prostate cancer patients receiving ADT.
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
RECRUITINGCARE-PC Web-Based Application Completion Rate
Completion rate measured as the proportion of participants successfully completing the web-based application out of the total number of subjects approached.
Time frame: 18 months
Patient acceptance and perception of the web-based application
Acceptance/perception measured by brief embedded survey following participation in the web-based application
Time frame: 18 months
Percent accuracy of patient-derived CV- and prostate cancer-related data elements
Accuracy assessed through parallel medical chart review by cardiology and oncology clinicians
Time frame: 18 months
Prevalence of CV risk factors/disease at the time of CARE-PC web-based application participation
Prevalence assessed through parallel medical chart review by cardiology and oncology clinicians
Time frame: 18 months
Proportion of participants with current cardiologist involvement in CV care at the time of web-based application participation
Patient reported cardiologist involvement via CARE-PC application at time of application survey completion
Time frame: 18 months
Proportion of participants engaging in CV care within 6 months of CARE-PC web application participation
CV care engagement assessed through medical chart review by investigators within 6 months post-application survey completion
Time frame: 18 months
Proportion of participants having changes in CV risk-reducing medications within 6 months of CARE-PC application participation.
Proportion of participants having changes in CV risk-reducing medications assessed through parallel medical chart review by cardiology and oncology clinicians within 6 months post-application survey completion
Time frame: 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.